NewsBenzingaXenetic Biosciences Announces Its Collaboration Partner PeriNess Doses First Participant In Clinical Trial Of Systemic Recombinant Human DNase To Treat Large B-Cell Lymphoma In Israel Xenetic Biosciences Announces Its Collaboration Partner PeriNess Doses First Participant In Clinical Trial Of Systemic Recombinant Human DNase To Treat Large B-Cell Lymphoma In Israel Benzinga 2026.10.15 12:49 (GMT+0) Open on Benzinga Other news Meta says Muse has over 10M users, with shopping a top activity One of Your Fuel Bills Is Poised to Be Lower This Year Year-old AI lab Flapping Airplanes raises $1B at a $6B valuation Strategy: I Called The Repeg, Now The Bitcoin Machine Can Restart (NASDAQ:MSTR) Teledyne Technologies Incorporated (TDY) Q3 2026 Earnings Call Transcript Stocks Rally on Positive AI News, with SpaceX up +7%
